List of Tables
Table 1. Global Targeted PSMA Radionuclide Drug Conjugates Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Targeted PSMA Radionuclide Drug Conjugates Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Targeted PSMA Radionuclide Drug Conjugates Market Competitive Situation by Manufacturers in 2025
Table 4. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Targeted PSMA Radionuclide Drug Conjugates Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Targeted PSMA Radionuclide Drug Conjugates Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Targeted PSMA Radionuclide Drug Conjugates, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Targeted PSMA Radionuclide Drug Conjugates, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Targeted PSMA Radionuclide Drug Conjugates, Product Types and Applications
Table 12. Global Key Manufacturers of Targeted PSMA Radionuclide Drug Conjugates, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted PSMA Radionuclide Drug Conjugates Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted PSMA Radionuclide Drug Conjugates Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted PSMA Radionuclide Drug Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Targeted PSMA Radionuclide Drug Conjugates Sales by Region (K Units), 2021–2026
Table 18. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Region (2021–2026)
Table 19. Global Targeted PSMA Radionuclide Drug Conjugates Sales by Region (K Units), 2027–2032
Table 20. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Region (2027–2032)
Table 21. Global Targeted PSMA Radionuclide Drug Conjugates Revenue by Region (US$ Million), 2021–2026
Table 22. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Region (2021–2026)
Table 23. Global Targeted PSMA Radionuclide Drug Conjugates Revenue by Region (US$ Million), 2027–2032
Table 24. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Region (2027–2032)
Table 25. North America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2021–2026
Table 27. North America Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2027–2032
Table 28. North America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2021–2026
Table 29. North America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Targeted PSMA Radionuclide Drug Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2021–2026
Table 32. Europe Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2027–2032
Table 33. Europe Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2021–2026
Table 42. Latin America Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2027–2032
Table 43. Latin America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Revenue by Country (US$ Million), 2027–2032
Table 50. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units) by Type (2021–2026)
Table 51. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units) by Type (2027–2032)
Table 52. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Type (2021–2026)
Table 53. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Type (2027–2032)
Table 54. Global Targeted PSMA Radionuclide Drug Conjugates Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Targeted PSMA Radionuclide Drug Conjugates Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Type (2021–2026)
Table 57. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Type (2027–2032)
Table 58. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Type (2021–2026)
Table 59. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Type (2027–2032)
Table 60. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units) by Application (2021–2026)
Table 61. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units) by Application (2027–2032)
Table 62. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Application (2021–2026)
Table 63. Global Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Application (2027–2032)
Table 64. Global Targeted PSMA Radionuclide Drug Conjugates Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Targeted PSMA Radionuclide Drug Conjugates Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Application (2021–2026)
Table 67. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Application (2027–2032)
Table 68. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Application (2021–2026)
Table 69. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Targeted PSMA Radionuclide Drug Conjugates Product
Table 74. Novartis Recent Developments/Updates
Table 75. Telix Pharmaceutical Company Information
Table 76. Telix Pharmaceutical Description and Business Overview
Table 77. Telix Pharmaceutical Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Telix Pharmaceutical Targeted PSMA Radionuclide Drug Conjugates Product
Table 79. Telix Pharmaceutical Recent Developments/Updates
Table 80. Lantheus Company Information
Table 81. Lantheus Description and Business Overview
Table 82. Lantheus Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Lantheus Targeted PSMA Radionuclide Drug Conjugates Product
Table 84. Lantheus Recent Developments/Updates
Table 85. University of California Company Information
Table 86. University of California Description and Business Overview
Table 87. University of California Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. University of California Targeted PSMA Radionuclide Drug Conjugates Product
Table 89. University of California Recent Developments/Updates
Table 90. Grand Pharmaceutical Company Information
Table 91. Grand Pharmaceutical Description and Business Overview
Table 92. Grand Pharmaceutical Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Grand Pharmaceutical Targeted PSMA Radionuclide Drug Conjugates Product
Table 94. Grand Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Targeted PSMA Radionuclide Drug Conjugates Distributors List
Table 98. Targeted PSMA Radionuclide Drug Conjugates Customers List
Table 99. Targeted PSMA Radionuclide Drug Conjugates Market Trends
Table 100. Targeted PSMA Radionuclide Drug Conjugates Market Drivers
Table 101. Targeted PSMA Radionuclide Drug Conjugates Market Challenges
Table 102. Targeted PSMA Radionuclide Drug Conjugates Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted PSMA Radionuclide Drug Conjugates
Figure 2. Global Targeted PSMA Radionuclide Drug Conjugates Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Targeted PSMA Radionuclide Drug Conjugates Market Share by Type: 2025 & 2032
Figure 4. Diagnostic Product Picture
Figure 5. Therapeutic Product Picture
Figure 6. Global Targeted PSMA Radionuclide Drug Conjugates Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Targeted PSMA Radionuclide Drug Conjugates Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Specialist Clinic
Figure 10. Other
Figure 11. Global Targeted PSMA Radionuclide Drug Conjugates Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Targeted PSMA Radionuclide Drug Conjugates Market Size (US$ Million), 2021–2032
Figure 13. Global Targeted PSMA Radionuclide Drug Conjugates Sales (K Units), 2021–2032
Figure 14. Global Targeted PSMA Radionuclide Drug Conjugates Average Price (US$/Unit), 2021–2032
Figure 15. Targeted PSMA Radionuclide Drug Conjugates Report Years Considered
Figure 16. Targeted PSMA Radionuclide Drug Conjugates Sales Share by Manufacturers in 2025
Figure 17. Global Targeted PSMA Radionuclide Drug Conjugates Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Targeted PSMA Radionuclide Drug Conjugates Players: Market Share by Revenue in Targeted PSMA Radionuclide Drug Conjugates in 2025
Figure 19. Targeted PSMA Radionuclide Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Targeted PSMA Radionuclide Drug Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Country (2021–2032)
Figure 22. North America Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Country (2021–2032)
Figure 23. United States Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Country (2021–2032)
Figure 26. Europe Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Country (2021–2032)
Figure 27. Germany Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Region (2021–2032)
Figure 34. China Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Country (2021–2032)
Figure 42. Latin America Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Targeted PSMA Radionuclide Drug Conjugates Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Targeted PSMA Radionuclide Drug Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Targeted PSMA Radionuclide Drug Conjugates by Type (2021–2032)
Figure 53. Global Revenue Market Share of Targeted PSMA Radionuclide Drug Conjugates by Type (2021–2032)
Figure 54. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Targeted PSMA Radionuclide Drug Conjugates by Application (2021–2032)
Figure 56. Global Revenue Market Share of Targeted PSMA Radionuclide Drug Conjugates by Application (2021–2032)
Figure 57. Global Targeted PSMA Radionuclide Drug Conjugates Price (US$/Unit) by Application (2021–2032)
Figure 58. Targeted PSMA Radionuclide Drug Conjugates Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
